|
|
|
Insider
Information: |
Tang Capital Partners Lp |
Relationship: |
10% Owner |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
123,746 |
|
Indirect Shares
|
35,438,120 |
|
|
Direct
Value |
$26,708 |
|
|
Indirect Value
|
$72,345,893 |
|
|
Total
Shares |
35,561,866 |
|
|
Total
Value |
$72,372,600 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
14
|
1
|
Stock
price went up :
|
3
|
0
|
Stock
price went down : |
11
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
-4.3%
|
-74.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ardea Biosciences Inc |
RDEA |
10% Owner |
2012-02-01 |
15,089 |
2012-02-01 |
3,800,634 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
2018-09-12 |
6,941 |
2018-09-12 |
5,844,562 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
2008-02-15 |
0 |
2008-02-19 |
25,953 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
2008-11-18 |
27,000 |
2008-11-18 |
3,706,926 |
Premium* |
|
Neose Technologies Inc |
NTEC |
10% Owner |
|
0 |
2008-09-30 |
10,412,306 |
Premium* |
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2008-08-29 |
4,716 |
2008-09-29 |
785,920 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
|
0 |
2010-01-14 |
2,715,852 |
Premium* |
|
Aradigm Corp |
ARDM |
10% Owner |
2008-10-21 |
70,000 |
2008-10-21 |
5,877,000 |
Premium* |
|
Penwest Pharmaceuticals Co |
PPCO |
10% Owner |
2009-01-09 |
0 |
2010-09-20 |
0 |
Premium* |
|
La Jolla Pharmaceutical Co |
LJPC |
|
|
0 |
2014-07-23 |
1,699,067 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2017-02-23 |
559,900 |
Premium* |
|
Aptevo Therapeutics Inc. |
APVO |
Exit Filing |
2020-11-04 |
0 |
2021-11-23 |
0 |
Premium* |
|
Jounce Therapeutics Inc |
JNCE |
10% Owner |
2023-03-13 |
0 |
2023-05-03 |
10,000 |
Premium* |
|
Tcr2 Therapeutics Inc. |
TCRR |
10% Owner |
2023-05-03 |
0 |
2023-06-01 |
0 |
Premium* |
|
Rain Therapeutics Inc. |
RAIN |
10% Owner |
2023-05-30 |
0 |
2024-01-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
176 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-05-24 |
4 |
B |
$3.51 |
$17,570 |
I/I |
5,000 |
771,455 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-02 |
4/A |
B |
$3.51 |
$17,570 |
I/I |
5,000 |
771,455 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-05-24 |
4 |
B |
$3.56 |
$17,800 |
I/I |
5,000 |
766,455 |
1.5 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2008-09-24 |
4 |
B |
$0.32 |
$18,313 |
I/I |
56,819 |
10,321,983 |
1.5 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2008-09-25 |
4 |
B |
$0.33 |
$18,399 |
I/I |
56,096 |
10,378,079 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-06-13 |
4 |
B |
$3.52 |
$19,360 |
I/I |
5,500 |
779,305 |
1.5 |
- |
|
JNCE |
Jounce Therapeutics Inc |
10% Owner |
|
2023-03-14 |
4 |
B |
$1.02 |
$20,651 |
I/I |
20,286 |
5,300,087 |
1.5 |
% |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-02-15 |
4 |
S |
$0.09 |
$22,221 |
I/I |
(258,686) |
46,050 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-12 |
4 |
B |
$1.80 |
$25,011 |
I/I |
13,895 |
4,702,608 |
1.5 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-12-14 |
4 |
S |
$1.21 |
$29,531 |
I/I |
(24,406) |
4,000,080 |
0 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-13 |
4 |
B |
$1.78 |
$30,533 |
I/I |
17,130 |
4,719,738 |
1.5 |
- |
|
NTEC |
Neose Technologies Inc |
10% Owner |
|
2008-09-22 |
4 |
B |
$0.32 |
$31,603 |
I/I |
100,200 |
10,251,914 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-11 |
4 |
B |
$1.30 |
$33,890 |
I/I |
25,100 |
6,396,598 |
1.5 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-02-23 |
4 |
B |
$1.42 |
$34,238 |
I/I |
24,140 |
5,575,336 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-03 |
4 |
B |
$1.85 |
$34,249 |
I/I |
18,513 |
3,944,800 |
1.5 |
% |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-01-03 |
4 |
B |
$4.21 |
$34,938 |
I/I |
8,300 |
1,581,129 |
1.5 |
- |
|
TCRR |
Tcr2 Therapeutics Inc. |
10% Owner |
|
2023-05-09 |
4 |
B |
$1.95 |
$39,275 |
I/I |
20,141 |
4,293,078 |
1.5 |
% |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-05-09 |
4 |
B |
$1.80 |
$42,421 |
I/I |
23,575 |
4,688,713 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-28 |
4 |
B |
$1.79 |
$44,750 |
I/I |
25,000 |
4,182,038 |
1.5 |
- |
|
NSTR |
Northstar Neuroscience In... |
10% Owner |
|
2008-04-08 |
4 |
B |
$1.83 |
$45,750 |
I/I |
25,000 |
3,290,400 |
1.5 |
- |
|
HRTX |
Heron Therapeutics Inc |
10% Owner |
|
2015-06-01 |
4 |
B |
$19.30 |
$45,934 |
I/I |
2,380 |
4,713,923 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-03-27 |
4 |
B |
$3.45 |
$48,300 |
I/I |
14,000 |
701,877 |
1.5 |
- |
|
RAIN |
Rain Therapeutics Inc. |
10% Owner |
|
2023-12-18 |
4 |
S |
$1.21 |
$48,560 |
I/I |
(40,132) |
3,850,513 |
0 |
- |
|
PPCO |
Penwest Pharmaceuticals C... |
10% Owner |
|
2009-03-10 |
4 |
B |
$1.43 |
$50,050 |
I/I |
35,000 |
6,371,498 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2006-12-27 |
4 |
B |
$4.07 |
$50,070 |
I/I |
12,300 |
103,294 |
1.5 |
- |
|
176 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|